L3VLUP
ProSign in

SGHT in the 13F filings

Sight Sciences Inc · CUSIP 82657M105

Sector · Medical devices and instrumentsTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Surgical, medical and electromedical devices
Quarter
Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Quarter end
30 Jun 2023
the date the book describes
Filed
14 Aug 2023
latest of these filings; the earliest 9 Aug 2023
Managers listing it
2
at least, of 95 tracked, among listed positions
Comparable managers
93
filed both Q1 2023 and Q2 2023; 2 listed it in both
Shares listed
6,255,421
combined, among listed positions
Reported value
$52m
combined, at the quarter end

Managers listing SGHT in Q2 2023

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q1 2023, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

2 of 2 holders

ActionFiling
D1 Capital Partners LP5,852,036$48m0.93%Held014 Aug 2023 (the filing on sec.gov)
First Eagle Investment Management LLC403,385$3.3munder 0.1%Added+61,8739 Aug 2023 (the filing on sec.gov)

Largest increases and reductions, by shares

Q1 2023 to Q2 2023, among managers that listed it in both quarters or opened it.

Increases

Reductions

No reduction among listed positions.

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (0)

No new position among listed positions.

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
1 in Q4 2021 to 2 in Q3 2023

Tracked managers listing it, at least.

0123Q3 2021Q4 2021Q1 2022Q2 2022Q3 2022Q4 2022Q1 2023Q2 2023Q3 2023
the quarter shown share splitClick a quarter to open it.
SGHT by quarter
QuarterHoldersReported valueBuyersSellers
Q3 20213$134mn.a.n.a.
Q4 20211$103mn.a.n.a.
Q1 20221$68mn.a.n.a.
Q2 20222$53mn.a.n.a.
Q3 20222$39mn.a.n.a.
Q4 20222$76mn.a.n.a.
Q1 20232$54mn.a.n.a.
Q2 20232$52mn.a.n.a.
Q3 20232$22mn.a.n.a.

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

SGHT and LLY →SGHT and JNJ →SGHT and VRTX →Choose a stock to compare with SGHT →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own SGHT, latest filings →Back to the 13F Explorer →